RetroSense Therapeutics Finalist For Angel Award
ANN ARBOR — RetroSense Therapeutics LLC, the Ann Arbor pharma startup, said it had been selected as a finalist for the Luis Villalobos Award, sponsored by the Angel Capital Association. …
RetroSense Raises $6M To Develop Retinitis Pigmentosa Drug
ANN ARBOR — The privately held biopharmaceutical company RetroSense Therapeutics said Thursday it had raised $6 million in Series A financing to investigate the use of gene therapy and optogenetics …
RetroSense Gets Intellectual Property Deal
ANN ARBOR — The Ann Arbor biopharmaceutical startup RetroSense Therapeutics announced a license agreement for exclusive, worldwide rights to Massachusetts General Hospital’s patent application entitled “Method for Augmenting Vision in …
Ann Arbor Firm Gets Orphan Drug Status For RP Treatment
ANN ARBOR — Ann Arbor-based RetroSense Therapeutics LLC said it had received “orphan drug” status from the federal Food and Drug Administration for its lead drug candidate, RST-001, intended to …